Your search returned 40 studies. (Get alerts for new studies):
- Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Montgomery, Alabama
- Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Montgomery, Alabama
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure
Conditions: Hypertension - Heart Failure
Location: Montgomery, Alabama
- Examining the Use of Non-Invasive Inhaled Nitric Oxide to Reduce Chronic Lung Disease in Premature Newborns
Conditions: Bronchopulmonary Dysplasia
Location: Birmingham, Alabama
- Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients
Conditions: Fever
Location: Montgomery, Alabama
- Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients
Conditions: Fever
Location: Montgomery, Alabama
- A Comparison of an Investigational Dressing to Tegaderm Matrix Wound Dressing With PHI Technology in the Management of Diabetic Foot Ulcers
Conditions: Foot Ulcer, Diabetic
Location: Montgomery, Alabama
- Validation of Dyskinesia Rating Scales
Conditions: Parkinson's Disease
Location: Birmingham, Alabama
- Bone Mineral Density in HIV+ Patients
Conditions: Bone Mineral Density - Bone - Osteoporosis
Location: Birmingham, Alabama
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Birmingham, Alabama
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Birmingham, Alabama
- Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
Conditions: Arthritis, Rheumatoid - Osteoarthritis
Location: Montgomery, Alabama
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Albaster, Alabama
- A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
Conditions: Atopic Dermatitis
Location: Alexander City, Alabama
- Chronic Plaque Psoriasis (Ps) Registry
Conditions: Chronic Plaque Psoriasis
Location: Birmingham, Alabama
- Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
Conditions: Epilepsy With Simple or Complex Partial Onset Seizures
Location: Birmingham, Alabama
- Eslicarbazepine Acetate Monotherapy Long Term Study
Conditions: Epilepsy
Location: Birmingham, Alabama
- Confirmatory Study of 17P Versus Vehicle for the Prevention of Preterm Birth in Women With a Previous Singleton Spontaneous Preterm Delivery
Conditions: Preterm Birth
Location: Montgomery, Alabama
- A Study of Intravenously Administered Tamiflu (Oseltamivir) in Patients Over 13 Years of Age With Influenza
Conditions: Influenza
Location: Montgomery, Alabama
- Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)
Conditions: Diarrhea Predominant Irritable Bowel Syndrome
Location: Birmingham, Alabama
- A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection
Conditions: Children Whose Mothers Received 17P and Those Who Received Vehicle in the 17P Efficacy Trial
Location: Montgomery, Alabama
- Study to Assess Droxidopa in Treatment of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease
Conditions: Orthostatic Hypotension - Parkinson's Disease
Location: Alabaster, Alabama
- A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional A
Conditions: Type 2 Diabetes
Location: Birmingham, Alabama
- Vaginal and Rectal Clostridial Carriage Among Women of Reproductive Age in the United States
Conditions: Clostridium Sordellii - Clostridium Perfringens
Location: Montgomery, Alabama
- A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine
Conditions: Overactive Bladder
Location: Montgomery, Alabama
- Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema
Conditions: ACE Inhibitor Induced Angioedema
Location: Montgomery, Alabama
- BMS-790052 Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C
Conditions: Hepatitis C
Location: Montgomery, Alabama
- Allopurinol Outcome Study
Conditions: Gout
Location: Birmingham, Alabama
- Allopurinol Outcome Study
Conditions: Gout
Location: Calera, Alabama
- A Study in Adults With Type 2 Diabetes
Conditions: Diabetes Mellitus, Type 2
Location: Montgomery, Alabama
- Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain
Conditions: Low Back Pain
Location: Alabaster, Alabama
- A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opi
Conditions: Low Back Pain
Location: Alabaster, Alabama
- Study With PegInterferon Alfa-2a, Ribavirin and BMS-790052 With or Without BMS-650032 for Participants in Some Hepatitis C Virus (HCV) Trials
Conditions: Hepatitis C Virus
Location: Montgomery, Alabama
- Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Conditions: Abscess - Wound Infection - Surgical Site Infection - Cellulitis
Location: Montgomery, Alabama
- Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Cli
Conditions: Hepatitis C
Location: Montgomery, Alabama
- Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
Conditions: Diabetic Peripheral Neuropathy
Location: Birmingham, Alabama
- Study of the Efficacy and Safety of the Combination of Two FDA Approved Oral Medications, Nebivolol and Valsartan for Treatment of Stage 1 or 2 Hypert
Conditions: Stage 1 Hypertension - Stage 2 Hypertension
Location: Birmingham, Alabama
- Lesinurad Monotherapy in Gout Subjects Intolerant to Xanthine Oxidase Inhibitors
Conditions: Gout
Location: South Birmingham, Alabama
- Combining Lesinurad With Allopurinol in Inadequate Responders
Conditions: Gout
Location: Birmingham, Alabama
- Combining Lesinurad With Allopurinol in Inadequate Responders
Conditions: Gout
Location: Calera, Alabama
|